EFFECT OF NATURAL SEQUENCE VARIATION AT THE H-2L(D)-RESTRICTED CD8(-CELL EPITOPE OF THE MURINE CYTOMEGALOVIRUS IE1-ENCODED PP89 ON T-CELL RECOGNITION() T)
Pa. Lyons et al., EFFECT OF NATURAL SEQUENCE VARIATION AT THE H-2L(D)-RESTRICTED CD8(-CELL EPITOPE OF THE MURINE CYTOMEGALOVIRUS IE1-ENCODED PP89 ON T-CELL RECOGNITION() T), Journal of General Virology, 77, 1996, pp. 2615-2623
The amino acid sequence YPHFMPTNL of pp89, the ie 1-encoded product of
murine cytomegalovirus (MCMV; Smith strain), constitutes an immunodom
inant T cell epitope recognized in association with H-2L(d), Nucleotid
e sequencing of MCMV isolates derived from wild mice identified variat
ion between amino acids 147-192 of pp89 in 19 of 27 isolates, includin
g the region encompassing the CTL epitope (amino acid residues 168-176
), Four groups of isolates with naturally occurring variant sequences
for the CTL epitope were defined: (1) YPHFMPPNL; (2) <YPHFMP(PS)under
bar L>; (3) <YPHF(I)under bar P(PS)under bar L>; and (4) <Y(LD)under b
ar FMP(P)under bar NL>. The remaining isolates, and the laboratory str
ains K181 and Vancouver, showed complete identity with the Smith strai
n, Polyclonal pp89 (Smith strain)-specific CTL only weakly recognized
target cells infected with MCMV from most variant groups, No lysis of
cells infected with isolate N1 from group 4 was detected, Analyses of
crossreactive recognition of YPHFMPTNL peptide-coated targets by CTL p
rimed with variant MCMV isolates showed that the group 2 and 3 isolate
s, G4 and K6, respectively, but not the group 4 isolate N1, elicited C
TL that exhibited a cross-reactive response, Furthermore, while the gr
oup 2 and 3 isolates G4 and K6 were able to prime CTL responses that d
isplayed reactivity to homologous pp89 variant nonapeptides, the group
4 isolate N1 failed to do so, Finally, while immunization of mice wit
h the nonapeptide YPHFMPTNL conferred significant protection against t
he laboratory strain K181, no evidence of protection was observed for
the group 2 and 4 variants G4 and N1, respectively, These observations
raise the possibility that clinical isolates of HCMV may also differ
in sequence from potential vaccine strains at immunodominant epitopes
for CD8(+) T cells thus reducing the efficacy of vaccination.